In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Johnson & Johnson (JNJ) has reportedly revised its forecast of the impact of U.S. President Donald Trump’s tariffs to $200 ...

American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

President Trump’s approach to setting tariff rates is causing anxiety in the business community, with the trickling flow of letters to trad​e partners exacerbating concerns over hits to the ...